Low glycaemic index and low glycaemic load diets may avert type 2 diabetes development: Study Medha Baranwal12 April 2024 9:45 AM ISTCanada: In a multinational cohort spanning five continents, a higher risk of incident type 2 diabetes was observed with diets having a high glycaemic...
Trigonelline supplementation has therapeutic potential for age-associated muscle decline in sarcopenia: Study Medha Baranwal12 April 2024 9:00 AM ISTSwitzerland: A research team, including researchers from Nestle Research, revealed that a compound found in fenugreek and coffee, but also made in the...
Study compares patch test positivity: 24 versus 48 hours of occlusion time in allergic contact dermatitis patients Medha Baranwal12 April 2024 7:30 AM ISTIndia: A recent prospective study published in Contact Dermatitis compared patch test positivity after 24 and 48 hours of occlusion time in patients...
Transarterial chemoembolization and sorafenib combo improves survival in hepatocellular patients with PVTT: JAMA Medha Baranwal12 April 2024 7:30 AM ISTChina: A recent study showed a longer recurrence-free survival and overall survival with the combination of sorafenib and transarterial...
Lower oxygenation target in ICU patients with COVID-19 tied to more days alive without life support: JAMA Medha Baranwal12 April 2024 7:00 AM ISTDenmark: An arterial oxygen pressure (PaO2) target of 60 mm Hg versus 90 mm Hg led to more days alive without support in intensive care unit (ICU)...
Seizure prophylaxis in mild and moderate TBI tied to reduced risk of early posttraumatic seizures: JAMA Medha Baranwal11 April 2024 8:00 PM ISTUSA: A recent meta-analysis including 8 studies has suggested a small, albeit significant, reduced risk for early posttraumatic seizures (PTS) for...
Coronary sinus reducer improves symptoms in patients with refractory angina: ORBITA-COSMIC trial Medha Baranwal11 April 2024 10:00 AM ISTUK: A coronary sinus reducer (CSR) implant showed a symptom alleviation benefit for people with stable coronary artery disease and refractory angina,...
Bexagliflozin found as effective as dapagliflozin for glycemic control in diabetes: Study Medha Baranwal11 April 2024 9:30 AM ISTChina: A 24-week, phase 3 trial has shed light on the safety and efficacy of bexagliflozin versus dapagliflozin as an adjunct to metformin in Chinese...
Lowering cholesterol intake alone may not be enough to prevent CKD, study finds Dr Kartikeya Kohli11 April 2024 7:00 AM ISTSouth Korea: Findings from two Korean cohort studies revealed that simply lowering cholesterol intake may not be sufficient to prevent chronic kidney...
Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial Medha Baranwal10 April 2024 9:30 PM ISTSweden: Findings from the REDUCE-AMI published in The New England Journal of Medicine have shown no benefit of beta-blockers in revascularized...
Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study Medha Baranwal10 April 2024 10:00 AM ISTSouth Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded...
MR Study sheds light on anti-inflammatory effects of SGLT-2 inhibitors and their beneficial impact in reducing HF risk Medha Baranwal10 April 2024 10:00 AM ISTChina: A two-sample Mendelian randomization (MR) study provides genetic evidence supporting the anti-inflammatory effects of sodium-glucose...
